BCBS North Carolina Medical Policy Updates – September 2018

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

September 2018 Medical Policy Updates:

• Artificial Intervertebral Disc
• Bone Morphogenetic Protein
• Carrier Screening for Genetic Disease
• Electrodiagnostic Studies
• Endovascular Therapies for Extracranial Vertebral Artery Disease
• Genetic Testing for Alpha Thalassemia
• Genetic Testing for Duchenne and Becker Muscular Dystrophy
• Genetic Testing for Hereditary Hearing Loss
• Genetic Testing for Hereditary Pancreatitis
• Genetic Testing for Lactase Insufficiency
• Genetic Testing for Neurofibromatosis
• Genetic Testing for PTEN Hamartoma Tumor Syndrome
• Genetic Testing for Statin Induced Myopathy
• Genetic Testing for the Diagnosis of Inherited Peripheral Neuropathy
• Intensity Modulated Radiation Therapy (IMRT) of the Chest
• Interferential Stimulation
• Intraoperative Neurophysiologic Monitoring (sensory-evoked potentials, motor-evoked potentials, EEG monitoring)
• Neurosimulation Electrical
• Orthotics
• Oscillatory Devices for the Treatment of Respiratory Conditions
• Paraspinal Surface Electromyography (SEMG)
• Pharmacogenetic Testing for Drug Metabolism
• Quantitative Sensory Testing
• Sphenopalatine Ganglion Block for Headache

Added 9/21/2018;

• Abdominoplasty, Panniculectomy and Lipectomy
• Amniotic Membrane and Amniotic Fluid Injections
• Bioengineered Skin and Tissue
• Breast Surgeries
• Clinical Trial Services
• Composite Allotransplantation of the Hand and Face
• Cosmetic and Reconstructive Surgery
• Cranial Electrotherapy Stimulation (CES) and Auricular Electrostimulation
• Enzyme Replacement Therapy (ERT) for Lysosomal Storage Disorders
• Gene Expression Profiling for Cutaneous Melanoma
• Genetic Testing for Heterozygous Familial Hypercholesterolemia
• Genetic Testing for Myeloproliferative Neoplasms
• Genetic Testing for Statin Induced Myopathy
• Growth Factors in Wound Healing
• Immunoglobulin Therapy
• KRAS, NRAS, BRAF Mutation Analysis and Related Treatment in Metastatic Colorectal Cancer
• Laser Treatment of Port Wine Stains
• Lung and Lobar Lung Transplantation
• Microarray-based Gene Expression Testing for Cancers of Unknown Primary
• MRI-Guided Focused Ultrasound (MRgFUS)
• Multigene Expression Assay for Predicting Recurrence in Colon Cancer
• Ovarian and Internal Iliac Vein Embolization
• Reconstructive Eyelid Surgery and Brow Lift
• Rhinoplasty
• Septoplasty
• Surgical Treatment of Chest Wall Deformities
• Tinnitus Treatment

Added 9/27/2018;

• Antiemetic Injection Therapy
• Aqueous Shunts and Devices for Glaucoma
• Automated Percutaneous and Endoscopic Discectomy
• Cardiac (Heart) Transplantation
• Chemotherapy for Malignant Disease
• Common Genetic Variants to Predict Risk of Nonfamilial Breast Cancer
• Computerized Corneal Topography
• Drug Testing in Pain Management and Substance Abuse Treatment
• Extracorporeal Photopheresis
• Genetic and Protein Biomarkers for Diagnosis and Risk Assessment of Prostate Cancer
• Genetic Testing for Breast and Ovarian Cancer
• Genetic Testing For Colon Cancer
• Glaucoma, Evaluation by Ophthalmologic Techniques
• heart_lung_transplantation.pdf
• Hyperthermic Intraperitoneal Chemotherapy
• Interspinous Fixation Fusion Devices
• Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients with Cancer
• Measurement of Serum Antibodies to Infliximab and Adalimumab
• Molecular Analysis for Targeted Therapy for Non-Small Cell Lung Cancer (NSCLC)
• Molecular Markers in Fine Needle Aspirates of the Thyroid
• Molecular Panel Testing of Cancers to Identify Targeted Therapies
• Observation Room Services
• Polysomnography for Non‒Respiratory Sleep Disorders
• Renal (Kidney) Transplantation
• Serum Biomarker Panel Testing for Systemic Lupus Erythematosus
• Small Bowel, Small Bowel with Liver, or Multivisceral Transplant
• Viscocanalostomy and Canaloplasty
• Xolair Omalizumab

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.